LONDON, March 19, 2014 /PRNewswire/ --
The US markets saw a positive sentiment on Tuesday, March 18, 2014, with the NASDAQ
Composite closing at 4,333.31, up 1.25%, the Dow Jones Industrial
Average ending the session at 16,336.19, up 0.55% and the S&P
500 edging 0.72% higher to finish the trading session at 1,872.25.
During the session, gains in the Information Technology, Health
Care, and Energy sectors positively impacted the broader market. A
number of stocks saw large movements, including Synta
Pharmaceuticals Corp. (NASDAQ: SNTA), BG Medicine Inc. (NASDAQ:
BGMD), Abraxas Petroleum Corp. (NASDAQ: AXAS), and xG Technology
Inc. (NASDAQ: XGTI). Free technical research on SNTA, BGMD, AXAS
and XGTI can be downloaded upon signing up at:
http://www.investor-edge.com/318-register
Shares in Synta Pharmaceuticals Corp. edged 8.28% higher, finishing
Tuesday's session at $4.71. The stock
fluctuated between $4.34 and $4.76
during the session with a trading volume of 3.39 million shares as
compared to a three months average volume of 2.42 million shares.
Shares in Synta Pharmaceuticals Corp. have gained 8.03% in the
previous three trading sessions and 8.53% in the last three months,
while the same has fallen by 10.11% on YTD basis. The S&P 500
Health Care Sector Index mapped a gain of 1.17% during the trading
session and charted up 1.47% in the last one month. Furthermore,
the stock is trading at the RSI of 31.08 and below its 50-day and
200-day moving averages of $5.84 and
$5.58, respectively. Sign up today to
read free research on SNTA at:
http://www.investor-edge.com/318-SNTA-19Mar2014.pdf
BG Medicine Inc.'s stock closed Tuesday's session at $1.85, which is 31.21% higher than the previous
day's closing price of $1.41. A total
of 9.30 million shares were traded as compared to a three months
average volume of 1.51 million shares. The stock oscillated between
$1.46 and $1.87 during the trading
session. BG Medicine Inc.'s shares have surged 42.31% in the
previous three trading sessions, 43.97% in the last one month and
77.88% on YTD basis. The S&P 500 Health Care Sector Index
mapped a gain of 1.17% during the trading session and charted up
8.57% in the previous three months. Moreover, the stock is trading
at the RSI of 59.46 and above its 50-day and 200-day moving
averages of $1.29 and $1.06, respectively. Sign up today to read free
research on BGMD at:
http://www.investor-edge.com/318-BGMD-19Mar2014.pdf
On Tuesday, shares in Abraxas Petroleum Corp. ended the session at
$3.91, up 6.79%, hitting a new
52-week high of $3.96. A total of
3.41 million shares were traded as compared to a three months
average volume of 1.00 million shares. During the session, the
stock traded between $3.70 and $3.96.
The company's shares have advanced 19.16% in the last one month and
21.76% in the previous three months. Abraxas Petroleum Corp.'s
shares traded at a PE ratio of 17.70 and have gone up 19.85% on YTD
basis. The S&P 500 Energy Sector Index mapped a gain of 0.78%
during the trading session and charted up 1.40% in the last one
month. Further, the stock is trading at the RSI of 66.99 and above
its 50-day and 200-day moving averages of $3.25 and $2.89,
respectively. Sign up today to read free research on AXAS at:
http://www.investor-edge.com/318-AXAS-19Mar2014.pdf
xG Technology Inc.'s stock finished Tuesday's session at
$3.46, recording a 28.62% gain. A
total of 6.08 million shares were traded which is above the three
months average volume of 0.96 million shares. The stock vacillated
between $2.63 and $3.85 during the
session. xG Technology Inc.'s shares have rallied 160.15% in the
last one month and 118.99% on YTD basis. The S&P 500
Telecommunication Services Sector Index mapped a gain of 0.66%
during the trading session and charted up 1.21% in the last one
month. Additionally, the stock is trading at the RSI of 54.28 and
above its 50-day moving average of $1.90. Sign up today to read free research on
XGTI at:
http://www.investor-edge.com/318-XGTI-19Mar2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
3. This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at
compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage
on your company? Send us a full investors' package to research [at]
http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis.
This document, article or report is prepared and authored by
Investor-edge. An outsourced research services provider represented
by Nidhi Vatsal, CFA, has only reviewed the information provided by
Investor-edge in this article or report according to the Procedures
outlined by Investor-edge. Investor-edge is not entitled to veto or
interfere in the application of such procedures by the outsourced
provider to the articles, documents or reports, as the case may
be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or
otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Investor-edge
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Investor-edge expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Investor-Edge